Dr. Hibah Shaath
Senior Research Associate
Educational Qualifications
PhD Biomedical and Biological Sciences
MRes Genetic Medicine
Entity
Qatar Biomedical Research Institute
Divison
Translational Oncology Research Center
Biography
Dr. Hibah Shaath obtained her Bachelor of Science (Hons) and Master of Research (MRes) degrees in Genetics and Genetic Medicine from the University of Manchester. The focus of her MRes was the biomolecular characterization of Keratoconic corneas associated with transplant rejection. In 2013 she moved to Qatar and joined Shafallah Medical Genetics Center, where her main focus was identifying candidate genes with novel mutations associated with both Mendelian hereditary disease and ASD, through homozygosity mapping and family screening, presented in several posters at ARC’13 and ARC’14. In 2014, Dr. Shaath joined QBRI to work as a Research Associate in the Translational Oncology Research Center. In 2022, she completed her PhD in Biomedical and Biological Sciences from the College of Health and Life Sciences (CHLS) at HBKU under the supervision of Dr. Nehad Alajez. Her research focus is on the transcriptional landscape of colorectal cancer and breast cancer for novel biomarker discovery and targeted therapy. Her research was selected for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU, and in 2022; her poster was selected for Best Poster Award in the student category as the third place winner at HBKU Research Day.
PhD Biomedical and Biological Sciences
College of Health and Life Sciences
September 2017 - June 2022
MRes Genetic Medicine
The University of Manchester
September 2011 - September 2012
BSc (Honors) Genetics
The University of Manchester
September 2007 - June 2010
Research Associate
Qatar Biomedical Research Institute (QBRI) - Doha, Qatar
June 2014 - Present
Research Associate
Shafallah Medical Genetics Center- Doha, Qatar
January 2013 - June 2014
- HBKU Research Day: Best Poster Award, Student Category; third place winner for poster on Therapeutic targeting for Colorectal Cancer: Toward Precision Medicine
- Abstract chosen for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU: Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy